awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41386664-FC8CB6F1-66ED-4A56-862B-1D48D1A8D919
Q41386664-FC8CB6F1-66ED-4A56-862B-1D48D1A8D919
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41386664-FC8CB6F1-66ED-4A56-862B-1D48D1A8D919
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.
P2093
Q41386664-FC8CB6F1-66ED-4A56-862B-1D48D1A8D919
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41386664-FC8CB6F1-66ED-4A56-862B-1D48D1A8D919
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
80010b3a2d7be4b4b250900102dbb38e12bd458a
P1545
11
http://www.w3.org/2001/XMLSchema#string
P2093
Carlo Pozzilli
http://www.w3.org/2001/XMLSchema#string